Zhongchao announced that its MDMOOC Platform will apply the ChatGPT, or Chat Generative Pre-trained Transformer, to provide assistance for physicians in clinical decision-making to improve the efficiency of diagnosis and treatment. This is an expanded application of ChatGPT by Zhongchao since its initial application of ChatGPT to elevate patient management service capabilities and experience. The application of ChatGPT will be available on the MDMOOC ChatGPT Wechat Public Account, a public account on WeChat. Physicians can utilize MDMOOC ChatGPT to access the latest information on diseases, diagnostic criteria, treatment options, research data, and guidelines. In addition, physicians will be alerted that contents provided by ChatGPT will be solely for reference and convenience to users and shall not be relied on for diagnostic or treatment purposes. The application of ChatGPT will allow physicians to quickly comprehend multidisciplinary knowledge and clinical data as needed in developing comprehensive and up-to-date treatment plans for individual patients.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ZCMD:
